Jecko Thachil/LinkedIn
Mar 14, 2026, 15:40
Jecko Thachil: Anticoagulation in Patients With Metabolic-Associated Fatty Liver Disease
Jecko Thachil, Consultant Haematologist at NHS, shared a post on LinkedIn about about a recent article he and his colleagues co-authored, adding:
“Patients with liver disease were historically considered to be at increased risk of bleeding. But, now we know that such patients may actually be at increased risk of thrombosis, especially in setting of metabolic associated fatty liver disease or staetohepatitis.
How do we anticoagulate such patients?”
Title: The prothrombotic tendency of metabolic-associated fatty liver disease
Authors: Dawn Swan, Ton Lisman, Armando Tripodi, Jecko Thachil
Read the Full Article on Journal of Thrombosis and Haemostasis
Other posts featuring Jecko Thachil on Hemostasis Today.
-
Sep 30, 2026, 10:55Rana Al Hrout: Diagnostic Approach to Hypochromic Microcytic Anemia
-
Sep 30, 2026, 01:52Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 30, 2026, 01:51How a Venous Thrombus Becomes Revascularized – ISTH
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice